Additionally, G9a may interact with EZH2 allowing the silencing of specific loci in a cooperative way (Mozzetta et al., 2014; Mozzetta et al., 2015) becoming a possible target for advanced metastatic BC (Segovia et al., 2019). Here, EHMT2 is linked to breast cancer.